Dr. Benjamin M. Ellingson's lab at UCLA focuses on understanding glioblastoma, an aggressive form of brain cancer, and developing better imaging methods to guide treatment. His team investigates how certain proteins and imaging techniques can predict patient response to therapies that block blood vessel growth. By combining advanced MRI imaging with clinical data, they aim to create reliable biomarkers that help tailor treatments, improving outcomes for patients battling this challenging disease.

Dr. Neema Jamshidi's research lab at UCLA focuses on improving our understanding and treatment of pancreatic cancer, a highly aggressive type of cancer with poor survival rates. The lab integrates various diagnostic techniques, including imaging and molecular profiling, to identify distinct characteristics of the tumor environment. By combining data from multiple sources, they aim to create non-invasive imaging tests for better diagnosis and potential new treatment targets.

Dr. Kamariza's lab focuses on developing innovative diagnostic tools to tackle tuberculosis, particularly drug-resistant strains. By creating a new rapid drug susceptibility test, the lab aims to improve the identification of TB and its resistance to treatments, especially in low-resource settings. This research is crucial for enhancing global healthcare responses to tuberculosis, a leading infectious disease threat.

The lab directed by Dr. Song Li at UCLA focuses on cell engineering, particularly enhancing the process of reprogramming somatic cells into induced neuronal cells using mechanical factors. They explore how manipulating the physical properties of cell nuclei can affect gene expression and chromatin structure, paving the way for advancements in regenerative medicine, disease modeling, and drug discovery.

Dr. Kyung Hyun Sung's lab at UCLA focuses on improving the detection and diagnosis of aggressive prostate cancer, particularly among African American men who are disproportionately affected by this disease. Using advanced MRI techniques and innovative software tools, the lab aims to develop more accurate imaging models that account for racial differences in prostate cancer characteristics. The ultimate goal is to reduce disparities in prostate cancer diagnosis and treatment outcomes through enhanced imaging and analysis methods.

Dr. Frank Pajonk's lab at UCLA focuses on improving radiation therapy for patients with glioblastoma, a type of brain cancer. The research targets the unique properties of cancer stem cells that make tumors resistant to treatment, specifically looking for ways to promote the differentiation of these cells into non-cancerous types. By developing new compounds that can cross the blood-brain barrier, the lab aims to enhance the effectiveness of radiotherapy and ultimately improve patient outcomes.

At Dr. Dorthe Schaue's lab at UCLA, researchers focus on using a new imaging technique called autofluorescence to measure how much radiation exposure organisms have experienced. This research aims to develop a way to quickly assess radiation damage, which is crucial for making timely medical decisions during emergencies. By studying how cells respond to radiation at the molecular level, the lab hopes to create a tool that can predict acute health risks related to radiation and enhance safety protocols during radiological events.

Dr. Liang Gao's lab at UCLA focuses on advanced imaging techniques to study heart and brain activity in real time. The research uses innovative optical methods, particularly in zebrafish models and neuronal networks, to explore the underlying mechanisms of cardiac arrhythmias like atrial fibrillation and the dynamics of neuronal signaling. This work has the potential to enhance our understanding of heart conditions and neuronal behavior at the cellular level.

Professor Jun Chen's lab at UCLA is focused on creating innovative vascular grafts that can continuously monitor blood flow and detect issues like stenosis without invasive procedures. They are developing a new type of graft that uses advanced materials to wirelessly transmit health data in real-time, which can help improve patient outcomes after surgeries. The lab combines expertise in bioengineering, tissue engineering, and artificial intelligence to address significant challenges in vascular health management.

Dr. Holden H. Wu's lab at UCLA focuses on improving the diagnosis and treatment of liver diseases and abdominal cancers using advanced MRI technology. The team develops new non-invasive imaging techniques that help doctors distinguish between different types of liver disease and enhance real-time guidance for minimally invasive surgical procedures. This innovative research aims to reduce the need for invasive biopsies and improve patient outcomes in cancer treatment.